Search research articles
Contact Us
Filters
Showing results (781-790 of 910) with videos related to
Page
of 91
Sort By:
International Journal of Cardiology
|
July 3, 2018
Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction
Ola Kleveland, Thor Ueland, Gabor Kunszt, et al.
Scientific Reports
|
May 2, 2018
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
Hedda Hoel, Malene Hove-Skovsgaard, Johannes R Hov, et al.
ESC Heart Failure
|
January 25, 2020
Low fibre intake is associated with gut microbiota alterations in chronic heart failure
Cristiane C K Mayerhofer, Martin Kummen, Kristian Holm, et al.
Journal of the American Heart Association
|
May 22, 2016
NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
Geena Paramel Varghese, Lasse Folkersen, Rona J Strawbridge, et al.
Plos One
|
October 14, 2015
Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
Yangchen Dhondup, Ivar Sjaastad, Helge Scott, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2010
Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
Tuva B Dahl, John Willy Haukeland, Arne Yndestad, et al.
Psychological Medicine
|
January 29, 2019
Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors
Ragni H Mørch, Ingrid Dieset, Ann Færden, et al.
Journal of Neurology
|
March 20, 2021
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
Anne Hege Aamodt, Einar August Høgestøl, Trine Haug Popperud, et al.
JACC. Advances
|
June 26, 2025
Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac Amyloidosis
Margrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
Journal of Clinical Lipidology
|
December 28, 2020
Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers
Anders Hovland, Ingunn Narverud, Linn Kristin Lie Øyri, et al.
Page
of 91
Search research articles
Search
Showing results (781-790 of 910) with videos related to
Sort By:
Page
of 91
International Journal of Cardiology
|
July 3, 2018
Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction
Ola Kleveland, Thor Ueland, Gabor Kunszt, et al.
Scientific Reports
|
May 2, 2018
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
Hedda Hoel, Malene Hove-Skovsgaard, Johannes R Hov, et al.
ESC Heart Failure
|
January 25, 2020
Low fibre intake is associated with gut microbiota alterations in chronic heart failure
Cristiane C K Mayerhofer, Martin Kummen, Kristian Holm, et al.
Journal of the American Heart Association
|
May 22, 2016
NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
Geena Paramel Varghese, Lasse Folkersen, Rona J Strawbridge, et al.
Plos One
|
October 14, 2015
Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
Yangchen Dhondup, Ivar Sjaastad, Helge Scott, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2010
Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
Tuva B Dahl, John Willy Haukeland, Arne Yndestad, et al.
Psychological Medicine
|
January 29, 2019
Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors
Ragni H Mørch, Ingrid Dieset, Ann Færden, et al.
Journal of Neurology
|
March 20, 2021
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
Anne Hege Aamodt, Einar August Høgestøl, Trine Haug Popperud, et al.
JACC. Advances
|
June 26, 2025
Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac Amyloidosis
Margrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
Journal of Clinical Lipidology
|
December 28, 2020
Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers
Anders Hovland, Ingunn Narverud, Linn Kristin Lie Øyri, et al.
Page
of 91